Should I Buy APOG? APOG 2026 Analysis

Should You Buy Apogee Enterprises Inc (APOG) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

41.790

1 Day change

2.88%

52 Week Range

52.100

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient trader: the tape is trying to rebound, but the dominant drivers are still negative (earnings miss + margin compression + legal/class-action overhang).
Best read is “hold/avoid new longs” unless you’re specifically trading a short-term bounce into ~40–41 resistance; upside exists, but the risk/reward is not clean enough to call this a buy today.
Intellectia Proprietary Trading Signals
AI Stock Picker: No signal on given stock today.
SwingMax: No signal on given stock today.

Technical Analysis

Pre-market price ~38.8 is slightly above the pivot (38.54), suggesting near-term stabilization after prior weakness.
MACD histogram +0.11 and expanding: momentum has turned positive short-term.
RSI(6) ~63: leaning bullish but not overbought; room to run, but not a strong “oversold bounce” setup anymore.
Moving averages converging: transition phase (no strong established trend), which often means choppy price action.
Key levels: Support S1 ~37.05 then S2 ~36.12; Resistance R1 ~40.04 then R2 ~40.96. A failed push near 40–41 would be a common sell/trim area.
Pattern-based projection: ~60% chance of modest gains (+0.35% next day, +2.12% next week, +8.65% next month), but these are relatively low edge vs. the headline risk.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Open interest put/call = 0.27: positioning skews bullish (more calls outstanding than puts).
However, today’s option volume is extremely light (2 puts, 0 calls): sentiment signal is weak due to low participation.
Implied vol (30d) ~57.2% vs historical vol ~29.6%: options are pricing elevated uncertainty (consistent with earnings/controversy headline risk).
IV percentile ~77.6: volatility is high versus the past year, often seen around unresolved negative catalysts (not ideal for “clean” long entries).

Technical Summary

Sell

Buy

Positive Catalysts

- Technical momentum has improved (positive, expanding MACD) and price is holding above the pivot.
- Prior analyst upgrade to Buy with $47 target implies meaningful upside if execution stabilizes.
- Call-heavy open interest (low put/call OI) can support a rebound if news flow quiets.

Neutral/Negative Catalysts

- Fiscal 2026 Q3 sales miss and commentary pointing to cost pressures (aluminum, restructuring, health insurance) keep fundamentals under pressure.
- Multiple headlines around Pomerantz investigation / potential class action: ongoing legal/governance overhang can cap valuation and spike volatility.
- Stock previously saw a sharp post-earnings drop (noted -13.89% on the earnings day), signaling fragile sentiment.
- Hedge funds and insiders show “Neutral” activity recently: no strong smart-money accumulation signal.

Financial Performance

Latest quarter: Fiscal 2026/Q3.
Revenue: $348.6M, +2.11% YoY (top-line growth is modest but positive).
Profitability deteriorated: Net income -21.15% YoY to $16.55M; EPS -19.79% YoY to $0.77.
Gross margin: 24.81% (down ~4.91% YoY), confirming cost inflation / mix issues and explaining why the stock is struggling despite revenue growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend provided: DA Davidson upgraded to Buy (from Neutral) on 2025-11-17, reiterated a $47 price target (unchanged).
Wall Street pros (bull case): shares may be discounting bad news; potential earnings power if margins stabilize; buybacks and segment momentum (Performance Surfaces) could help.
Wall Street cons (bear case): the more recent earnings miss, margin compression, and legal headlines can keep the stock trapped in a low-multiple/risk-off regime until there’s clear operational improvement.
Politicians / Congress trading: No recent congress trading data available (no influential-figure signal to lean on).

2 Analyst Rating

Wall Street analysts forecast APOG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for APOG is 45 USD with a low forecast of 44 USD and a high forecast of 46 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

Current: 40.620

Low

Averages

High

Current: 40.620

Low

Averages

High

DA Davidson

Brent Thielman

Neutral -> Buy

upgrade

$47

AI Analysis

2025-11-17

Reason

DA Davidson

Brent Thielman

Price Target

$47

AI Analysis

2025-11-17

upgrade

Neutral -> Buy

Reason

DA Davidson analyst Brent Thielman upgraded Apogee Enterprises to Buy from Neutral with an unchanged price target of $47. The over 50% drop in the shares year-to-date reflects reflects end market variability, tariff impacts and the CEO exit, the analyst tells investors in a research note. The shares at current levels are not pricing the momentum in the company's Performance Surfaces segment and its "aggressive" buybacks, the analyst tells investors in a research note. DA believes that if Apogee keeps margins on higher potential revenue in the next few years, the company has "significant earnings power" potential.

DA Davidson

Brent Thielman

Neutral -> Buy

upgrade

$47

2025-11-17

Reason

DA Davidson

Brent Thielman

Price Target

$47

2025-11-17

upgrade

Neutral -> Buy

Reason

DA Davidson analyst Brent Thielman upgraded Apogee Enterprises to Buy from Neutral with a $47 price target.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for APOG

Unlock Now

APOG Should I Buy

APOG Should I Buy

Should You Buy Apogee Enterprises Inc (APOG) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch